Entry Detail



General Information

Database ID:exR0080574
RNA Name:RPL13
RNA Type:mRNA
Chromosome:chr16
Starnd:+
Coordinate:
Start Site(bp):89560657End Site(bp):89566828
External Links:ENSG00000167526



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AGFG2
chr7
100539203
100568220
+
AC009690.1
chr15
72284727
72375981
-
ADO
chr10
62804720
62808479
+
AC008763.2
chr19
7629796
7643048
+
ALDH5A1
chr6
24494867
24537207
+
AK4
chr1
65147549
65232145
+
AGAP1
chr2
235494043
236131800
+
AAAS
chr12
53307456
53324864
-
AL136454.1
chr1
192716132
192716653
+
AL590132.1
chr1
210858125
211134146
-
ACTB
chr7
5527148
5563784
-
AC011455.2
chr19
38915404
38949855
-
ACAT2
chr6
159762045
159779112
+
ABCD3
chr1
94418389
94518666
+
AHCYL1
chr1
109984765
110023742
+
AK2
chr1
33007940
33080996
-
ACP1
chr2
264140
278283
+
AC004922.1
chr7
99325879
99394653
+
ADPRHL2
chr1
36088892
36093932
+
AARS2
chr6
44298731
44313347
-
AC006030.1
chr2
74211604
74363377
-
AIFM2
chr10
70098223
70132934
-
ACADM
chr1
75724347
75787575
+
AC026464.4
chr16
69299682
69322700
+
ADCY3
chr2
24819169
24919839
-
ACTR3
chr2
113890063
113962596
+
ADPGK
chr15
72751369
72785846
-
ACOT7
chr1
6264269
6394391
-
AKIRIN1
chr1
38991276
39006059
+
ALDH2
chr12
111766887
111817532
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-29c-3p
chr1
207801865
207801886
-
hsa-miR-4426
chr1
192716333
192716349
+
hsa-miR-4485-3p
chr11
10508277
10508296
-
hsa-miR-4521
chr17
8186948
8186969
+
hsa-miR-6716-3p
chr11
118644048
118644069
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002116.1
chr19
36008638
36014235
-
AC007952.4
chr17
19112000
19112636
-
AC009022.1
chr16
69976297
70065948
-
AC010542.4
chr16
66549280
66551189
+
AC011632.1
chr8
74798784
74866939
-
AC016747.1
chr2
61141592
61144969
-
AC020928.2
chr19
36773712
36775908
-
AC026362.1
chr12
122975320
122982907
+
AC026401.3
chr16
15701237
15702118
+
AC068768.1
chr12
123262060
123262402
+
AC091564.7
chr11
6610883
6616594
-
AC092143.3
chr16
89906157
89918233
+
AC100810.1
chr8
1761054
1764508
-
AC132217.1
chr11
2129121
2129964
-
AC133644.3
chr2
87455476
87767359
+
AC139149.1
chr17
81514047
81527776
+
AC215522.2
chr7
19018
35489
-
AC245014.3
chr1
145281116
145281462
+
AC245033.4
chr15
82533175
82540008
-
AD000090.1
chr19
35557956
35581954
+
AF106564.1
chr8
24912165
24914717
-
AL022311.1
chr22
37876148
37895563
+
AL022341.1
chr16
648473
649200
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA